Pharma Pricing & Market Access Congress 2017 London, England, UK 22-23 February 2017

Description:
Hear from an unprecedented number of international payers at our congress as we celebrate 10 successful years in 2017.

Learn how to prepare your market access strategy for the ever changing global healthcare market and understand the diverse payer landscape and how to influence decision making with insight from key payer organisations. It’s about getting the right drug, to the right patient, at the right cost and achieving maximum reimbursement success.

The event will cover a range of different topics including:
- How can we improve patient outcomes?
- Overcoming challenges in developing effective pricing strategies
- The future of cost effectiveness versus benefit driven evaluation globally
- Assess value frameworks
- Evaluate the current and future use of risk sharing agreements
- How to harmonize discussions and pricing approaches globally
- Discuss the impacts of Brexit on the international access landscape
There will be truly visionary keynotes, panel debates and roundtable discussions.

Prices:
2 Day Package: GBP 1395
3 Day Package: GBP 1895

Speakers: Thomas Mueller, Head of Pharmaceuticals, G-BA, David Watson, Director of Pricing & PPRS, ABPI, Francois Meyer, Advisor to the President, International Affairs, HAS, Sam Taylor, Global Pricing Director, Pfizer, Keiko Tone, VP, Global Market Access, Shionogi Limited, Francisco Zuluaga, Access, HEOR, Pricing Director South America, Bristol-Myers Squibb